Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: MCH Jurisdictional Survey Instrument for the Title V MCH Block Grant Program, OMB No. 0906-0042, Extension, 50365-50367 [2021-19447]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 171 / Wednesday, September 8, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
In addition, for evaluation of novel
excipients with a proposed use in
formulations for biological drug
products reviewed by CDER/OND,
submitters should provide:
• Stability studies of the excipient
under storage and potential in-use
conditions (e.g., over infusion time).
Novel excipients should be evaluated
for their potential to prevent
denaturation and degradation of
proteins during storage.
• For some excipients, studies should
address their potential protein-excipient
interaction and impact on drug product
immunogenicity as well as their
potential for masking process related
impurities.
Full packages should be submitted
through a Type V DMF or other master
file no later than 3 months after
notification that FDA has selected the
proposal. For more information on
submitting Type V DMFs, see the FDA
draft guidance for industry entitled
‘‘Drug Master Files’’ (Ref. 8).
FDA will evaluate the full package
and determine whether the excipient is
appropriate for the proposed use for use
in clinical trials. FDA will issue a letter
to the novel excipient submitter
announcing its decision.
For each novel excipient evaluated
under the second stage of the program,
FDA will publish on the Pilot Program
web page the initial proposal and the
determination letter. Information that
cannot be publicly disclosed will be
redacted. This web page will also
include a content outline identifying
information that should be included in
an Initial Proposal and other relevant
information regarding the pilot.
3. Effect of Determination
A determination that the excipient is
appropriate for use in clinical trials
means that FDA has determined it is
appropriate to use the novel excipient in
an IND within the defined use without
additional justification. However, the
drug sponsor would still need to
demonstrate that the excipient is safe in
the proposed formulation. The
information submitted under the full
package would remain in the Type V
DMF or other master file, and the master
file holder may grant authorization to
reference the information in the master
file at the holder’s discretion. Moreover,
we do not anticipate that a novel
excipient may be used in an abbreviated
new drug application because data and
information currently required to
support use of a novel excipient may
not be submitted in an abbreviated new
drug application. After it has been used
in approved drug products, the novel
excipient would be added to the
VerDate Sep<11>2014
17:21 Sep 07, 2021
Jkt 253001
Inactive Ingredient Database in
accordance with Agency practice.
If FDA determines that the excipient
is not appropriate for the proposed use,
an IND sponsor would be expected to
provide additional information to
demonstrate that the use of the novel
excipient is appropriate within the
context of the IND.
II. Paperwork Reduction Act of 1995
The information collection activities
associated with the Pilot Program refer
to previously approved FDA collections
of information. Therefore, clearance by
the Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501–
3521) is not required for this Pilot
Program. The previously approved
collections of information are subject to
review by OMB under the PRA. The
collections of information in 21 CFR
part 314 pertaining to the submission of
abbreviated new drug applications, new
drug applications, and DMFs have been
approved under OMB control number
0910–0001. The collections of
information in 21 CFR part 312
pertaining to the submission of IND
content and format; chemistry, control,
and manufacturing data; pharmacology
and toxicology data; and
pharmacokinetics and biological data
have been approved under OMB control
number 0910–0014. The collections of
information in 21 CFR part 58
pertaining to good laboratory practice
regulations for nonclinical laboratory
studies have been approved under OMB
control number 0910–0119. The
collections of information in 21 CFR
part 601 pertaining to biologics license
applications have been approved under
OMB control number 0910–0338.
III. References
The following references are on
display at the Dockets Management Staff
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, 240–402–
7500, and are available for viewing by
interested persons between 9 a.m. and 4
p.m., Monday through Friday; they are
also available electronically at https://
www.regulations.gov. FDA has verified
the website addresses, as of the date this
document publishes in the Federal
Register, but websites are subject to
change over time.
1. FDA, Guidance for Industry, ‘‘Nonclinical
Studies for the Safety Evaluation of
Pharmaceutical Excipients,’’ May 2005
(available at https://www.fda.gov/media/
72260/download). For the most recent
version of a guidance, check the FDA
guidance web page at https://
www.fda.gov/regulatory-information/
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
50365
search-fda-guidance-documents.
2. FDA Guidance for Industry, ‘‘S7A Safety
Pharmacology Studies for Human
Pharmaceuticals,’’ July 2001 (available at
https://www.fda.gov/media/72033/
download).
3. FDA, Guidance for Industry, ‘‘M3(R2)
Nonclinical Safety Studies for the
Conduct of Human Clinical Trials and
Marketing Authorization for
Pharmaceuticals,’’ January 2010
(available at https://www.fda.gov/media/
71542/download).
4. FDA, Guidance for Industry, ‘‘S2B
Genotoxicity: A Standard Battery for
Genotoxicity Testing of
Pharmaceuticals,’’ July 1997 (available at
https://www.fda.gov/media/71971/
download).
5. International Council for Harmonization
(ICH), Guidance for Industry, ‘‘Detection
of Reproductive and Developmental
Toxicity for Human Pharmaceuticals
S5(R3),’’ February 2020 (available at
https://database.ich.org/sites/default/
files/S5-R3_Step4_Guideline_2020_
0218_1.pdf).
6. FDA, Guidance for Industry, ‘‘The Need for
Long-term Rodent Carcinogenicity
Studies of Pharmaceuticals,’’ March 1996
(available at https://www.fda.gov/media/
71921/download).
7. FDA, Guidance for Industry, ‘‘S8
Immunotoxicity Studies for Human
Pharmaceuticals,’’ April 2006 (available
at https://www.fda.gov/media/72047/
download).
8. FDA, Draft Guidance for Industry ‘‘Drug
Master Files,’’ October 2019 (available at
https://www.fda.gov/media/131861/
download).
Dated: September 1, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–19335 Filed 9–7–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: MCH
Jurisdictional Survey Instrument for
the Title V MCH Block Grant Program,
OMB No. 0906–0042, Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 for opportunity
for public comment on proposed data
collection projects, HRSA announces
SUMMARY:
E:\FR\FM\08SEN1.SGM
08SEN1
50366
Federal Register / Vol. 86, No. 171 / Wednesday, September 8, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, or any other aspect of the ICR
related to the Maternal and Child Health
(MCH) Jurisdictional Survey that is to be
administered in the U.S. territories and
jurisdictions (excluding the District of
Columbia) for purposes of collecting
information related to the well-being of
all mothers, children, and their families.
DATES: Comments on this Information
Collection Request must be received no
later than November 8, 2021.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or by mail to the
HRSA Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
MCH Jurisdictional Survey Instrument
for the Title V MCH Block Grant
Program, OMB No. 0906–0042,
Extension.
Abstract: The purpose of the Title V
MCH Block Grant is to improve the
health of the nation’s mothers, infants,
children, including children with
special health care needs, and their
families by creating federal/state
partnerships that provide each state/
jurisdiction with needed flexibility to
respond to its individual MCH
population needs. Unique to the MCH
Block Grant is a commitment to
performance accountability, while
assuring state flexibility. Utilizing a
three-tiered national performance
measure framework, which includes
National Outcome Measures, National
Performance Measures, and EvidenceBased and Informed Strategy Measures,
State Title V programs report annually
on their performance relative to the
selected national performance and
outcome measures. Such reporting
VerDate Sep<11>2014
17:21 Sep 07, 2021
Jkt 253001
enables the state and federal program
offices to assess the progress achieved in
key MCH priority areas and to
document Title V program
accomplishments.
By legislation (Sections 505(a) and
506(a) of Title V of the Social Security
Act), the MCH Block Grant Application/
Annual Report must be developed by, or
in consultation with, the State MCH
Health agency. In establishing state
reporting requirements, HRSA’s
Maternal and Child Health Bureau
considers the availability of national
data from other federal agencies. Data
for the national performance and
outcome measures are pre-populated for
states in the Title V Information System.
National data sources identified for the
National Performance Measures and
National Outcome Measures in the MCH
Block Grant program seldom include
data from the Title V jurisdictions, with
the exception of the District of
Columbia. The eight remaining
jurisdictions (i.e., American Samoa,
Federated States of Micronesia, Guam,
Marshall Islands, Northern Mariana
Islands, Palau, Puerto Rico and U.S.
Virgin Islands) have limited access to
significant data and MCH indicators,
with limited capacity for collecting
these data.
Sponsored by HRSA’s Maternal and
Child Health Bureau, the MCH
Jurisdictional Survey is designed to
produce data on the physical and
emotional health of mothers and
children under 18 years of age in the
following eight jurisdictions—American
Samoa, Federated States of Micronesia,
Guam, Marshall Islands, Northern
Mariana Islands, Palau, Puerto Rico, and
Virgin Islands. More specifically, the
MCH Jurisdictional Survey collects
information on factors related to the
well-being of children, including health
status, visits to health care providers,
health care costs, and health insurance
coverage. In addition, the MCH
Jurisdictional Survey collects
information on factors related to the
well-being of mothers, including health
risk behaviors, health conditions, and
preventive health practices. This data
collection enables the jurisdictions to
meet federal performance reporting
requirements and to demonstrate the
impact of Title V funding relative to
MCH outcomes for the U.S. jurisdictions
in reporting on their unique MCH
priority needs.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
The MCH Jurisdictional Survey was
designed based on informationgathering activities with Title V
leadership and program staff in the
jurisdictions, experts at the Centers for
Disease Control and Prevention and
other organizations with relevant data
collection experience. Survey items are
based on the National Survey of
Children’s Health; the Behavioral Risk
Factor Surveillance System; the Youth
Behavior Surveillance System; and
selected other federal studies. The
Survey is designed as a core
questionnaire to be administered across
all jurisdictions with a supplemental set
of survey questions customized to the
needs of each jurisdiction.
Need and Proposed Use of the
Information: Data from the MCH
Jurisdictional Survey is used to measure
progress on national performance and
outcome measures under the Title V
MCH Block Grant Program. This survey
instrument is critical to collect
information on factors related to the
well-being of all mothers, children, and
their families in the jurisdictional Title
V programs, which address their unique
MCH needs.
Likely Respondents: The respondent
universe is women age 18 or older who
live in one of the eight targeted U.S.
jurisdictions (Puerto Rico, U.S. Virgin
Islands, Guam, Northern Mariana
Islands, American Samoa, Palau,
Marshall Islands, or Federated States of
Micronesia) and who are mothers or
guardians of at least one child aged
0–17 years living in the same
household.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. Included is the time needed
to review instructions; to develop,
acquire, install, and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
E:\FR\FM\08SEN1.SGM
08SEN1
50367
Federal Register / Vol. 86, No. 171 / Wednesday, September 8, 2021 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Adult Parents—Puerto Rico ..
Screener ................................
Core .......................................
Jurisdiction Module ...............
2,480
250
250
1
1
1
2,480
250
250
0.03
0.83
0.07
74.40
207.50
17.50
299.40
Adult Parents—U.S. Virgin Islands.
Screener ................................
Core .......................................
Jurisdiction Module ...............
2,153
250
250
1
1
1
2,153
250
250
0.03
0.83
0.07
64.59
207.50
17.50
289.59
Adult Parents—Guam ...........
Screener ................................
Core .......................................
Jurisdiction Module ...............
684
250
250
1
1
1
684
250
250
0.03
0.83
0.07
20.52
207.50
17.50
245.52
Adult Parents—American
Samoa.
Screener ................................
Core .......................................
Jurisdiction Module ...............
426
250
250
1
1
1
426
250
250
0.03
0.83
0.05
12.78
207.50
12.50
232.78
Adult Parents—Federated
States of Micronesia.
Screener ................................
Core .......................................
Jurisdiction Module ...............
339
250
250
1
1
1
339
250
250
0.03
0.83
0.05
10.17
207.50
12.50
230.17
Adult Parents—Marshall Islands.
Screener ................................
Core .......................................
Jurisdiction Module ...............
284
250
250
1
1
1
284
250
250
0.03
0.83
0.08
8.52
207.50
20.00
236.02
Adult Parents—Northern Mariana Islands.
Screener ................................
Core .......................................
Jurisdiction Module ...............
470
250
250
1
1
1
470
250
250
0.03
0.83
0.08
14.10
207.50
20.00
241.60
Adult Parents—Palau ............
Screener ................................
Core .......................................
Jurisdiction Module ...............
467
250
250
1
1
1
467
250
250
0.03
0.83
0.02
14.01
207.50
5.00
226.51
Total ...............................
................................................
7,303
........................
7,303
........................
........................
2,001.59
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–19447 Filed 9–7–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Average
burden per
response
(in hours)
Form name
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Submission for OMB Review; 30-Day
Comment Request; Evaluation of
Office of Acquisitions System (OASYS)
and FFRDC Contract Administration
System (FCAS) Vendor Portals
National Cancer Institute (NCI);
Correction
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice; correction.
VerDate Sep<11>2014
17:21 Sep 07, 2021
Jkt 253001
Number of
respondents
Number of
responses per
respondent
Type of
respondent
Total
responses
The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on August 31, 2021.
That Notice requires a correction in the
SUPPLEMENTARY INFORMATION section.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Marla Jacobson, 9609 Medical Center
Drive, MSC 9742, Rockville, MD 20850
or call non-toll-free number 240–276–
5267 or email your request, including
your address to: marla.jacobson@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of August 31,
2021, in FR Doc. 2021–18767, on page
48747, as found within the
SUPPLEMENTARY INFORMATION section,
within the Estimated Annualized
Burden Hours table for the Total Annual
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Burden hours
per form
Total
burden hours
Burden Hours for the form name
column Survey—FCAS total currently
reads ‘‘1’’ and is corrected to read: ‘‘0’’,
the form name column Registration—
FCAS total currently reads ‘‘1’’ and is
corrected to read: ‘‘0’’. These corrections
revise the Total Annual Burden Hours
total currently reads ‘‘232’’ and is
corrected to read: ‘‘230’’.
Dated: September 1, 2021.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2021–19281 Filed 9–7–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 86, Number 171 (Wednesday, September 8, 2021)]
[Notices]
[Pages 50365-50367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19447]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request; Information Collection Request Title: MCH
Jurisdictional Survey Instrument for the Title V MCH Block Grant
Program, OMB No. 0906-0042, Extension
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 for opportunity for public comment on proposed data
collection projects, HRSA announces
[[Page 50366]]
plans to submit an Information Collection Request (ICR), described
below, to the Office of Management and Budget (OMB). Prior to
submitting the ICR to OMB, HRSA seeks comments from the public
regarding the burden estimate, or any other aspect of the ICR related
to the Maternal and Child Health (MCH) Jurisdictional Survey that is to
be administered in the U.S. territories and jurisdictions (excluding
the District of Columbia) for purposes of collecting information
related to the well-being of all mothers, children, and their families.
DATES: Comments on this Information Collection Request must be received
no later than November 8, 2021.
ADDRESSES: Submit your comments to [email protected] or by mail to the
HRSA Information Collection Clearance Officer, Room 14N136B, 5600
Fishers Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
draft instruments, email [email protected] or call the HRSA
Information Collection Clearance Officer at (301) 443-1984.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the information request collection title
for reference.
Information Collection Request Title: MCH Jurisdictional Survey
Instrument for the Title V MCH Block Grant Program, OMB No. 0906-0042,
Extension.
Abstract: The purpose of the Title V MCH Block Grant is to improve
the health of the nation's mothers, infants, children, including
children with special health care needs, and their families by creating
federal/state partnerships that provide each state/jurisdiction with
needed flexibility to respond to its individual MCH population needs.
Unique to the MCH Block Grant is a commitment to performance
accountability, while assuring state flexibility. Utilizing a three-
tiered national performance measure framework, which includes National
Outcome Measures, National Performance Measures, and Evidence-Based and
Informed Strategy Measures, State Title V programs report annually on
their performance relative to the selected national performance and
outcome measures. Such reporting enables the state and federal program
offices to assess the progress achieved in key MCH priority areas and
to document Title V program accomplishments.
By legislation (Sections 505(a) and 506(a) of Title V of the Social
Security Act), the MCH Block Grant Application/Annual Report must be
developed by, or in consultation with, the State MCH Health agency. In
establishing state reporting requirements, HRSA's Maternal and Child
Health Bureau considers the availability of national data from other
federal agencies. Data for the national performance and outcome
measures are pre-populated for states in the Title V Information
System. National data sources identified for the National Performance
Measures and National Outcome Measures in the MCH Block Grant program
seldom include data from the Title V jurisdictions, with the exception
of the District of Columbia. The eight remaining jurisdictions (i.e.,
American Samoa, Federated States of Micronesia, Guam, Marshall Islands,
Northern Mariana Islands, Palau, Puerto Rico and U.S. Virgin Islands)
have limited access to significant data and MCH indicators, with
limited capacity for collecting these data.
Sponsored by HRSA's Maternal and Child Health Bureau, the MCH
Jurisdictional Survey is designed to produce data on the physical and
emotional health of mothers and children under 18 years of age in the
following eight jurisdictions--American Samoa, Federated States of
Micronesia, Guam, Marshall Islands, Northern Mariana Islands, Palau,
Puerto Rico, and Virgin Islands. More specifically, the MCH
Jurisdictional Survey collects information on factors related to the
well-being of children, including health status, visits to health care
providers, health care costs, and health insurance coverage. In
addition, the MCH Jurisdictional Survey collects information on factors
related to the well-being of mothers, including health risk behaviors,
health conditions, and preventive health practices. This data
collection enables the jurisdictions to meet federal performance
reporting requirements and to demonstrate the impact of Title V funding
relative to MCH outcomes for the U.S. jurisdictions in reporting on
their unique MCH priority needs.
The MCH Jurisdictional Survey was designed based on information-
gathering activities with Title V leadership and program staff in the
jurisdictions, experts at the Centers for Disease Control and
Prevention and other organizations with relevant data collection
experience. Survey items are based on the National Survey of Children's
Health; the Behavioral Risk Factor Surveillance System; the Youth
Behavior Surveillance System; and selected other federal studies. The
Survey is designed as a core questionnaire to be administered across
all jurisdictions with a supplemental set of survey questions
customized to the needs of each jurisdiction.
Need and Proposed Use of the Information: Data from the MCH
Jurisdictional Survey is used to measure progress on national
performance and outcome measures under the Title V MCH Block Grant
Program. This survey instrument is critical to collect information on
factors related to the well-being of all mothers, children, and their
families in the jurisdictional Title V programs, which address their
unique MCH needs.
Likely Respondents: The respondent universe is women age 18 or
older who live in one of the eight targeted U.S. jurisdictions (Puerto
Rico, U.S. Virgin Islands, Guam, Northern Mariana Islands, American
Samoa, Palau, Marshall Islands, or Federated States of Micronesia) and
who are mothers or guardians of at least one child aged 0-17 years
living in the same household.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. Included is the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
[[Page 50367]]
Total Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per Total per response Burden hours Total burden
respondents respondent responses (in hours) per form hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Puerto Rico........ Screener............ 2,480 1 2,480 0.03 74.40 299.40
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.07 17.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--U.S. Virgin Islands Screener............ 2,153 1 2,153 0.03 64.59 289.59
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.07 17.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Guam............... Screener............ 684 1 684 0.03 20.52 245.52
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.07 17.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--American Samoa..... Screener............ 426 1 426 0.03 12.78 232.78
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.05 12.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Federated States of Screener............ 339 1 339 0.03 10.17 230.17
Micronesia. Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.05 12.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Marshall Islands... Screener............ 284 1 284 0.03 8.52 236.02
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.08 20.00
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Northern Mariana Screener............ 470 1 470 0.03 14.10 241.60
Islands. Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.08 20.00
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adult Parents--Palau.............. Screener............ 467 1 467 0.03 14.01 226.51
Core................ 250 1 250 0.83 207.50
Jurisdiction Module. 250 1 250 0.02 5.00
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total......................... .................... 7,303 .............. 7,303 .............. .............. 2,001.59
--------------------------------------------------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-19447 Filed 9-7-21; 8:45 am]
BILLING CODE 4165-15-P
